Arotech Corporation ARTX, one of the hottest stocks under $10 on the market today, is engaged in the defense and security industry. The Delaware-based company produces batteries, electrical equipment, and multimedia training systems for military and homeland security applications. ARTX, which has gained nearly 45% over the past 12 weeks, is currently trading for $3.43 per share. Arotech currently holds a Zacks Rank #1 (Strong Buy), and its “A” grade for Growth in our Style Scores system implies that this low-priced stock could keep pushing forward. Of course, a solid Zacks Rank implies that Arotech has seen earnings success recently. Last quarter, the company posted a surprise profit of five cents, which beat that Zacks Consensus Estimate by 600%. Additionally, we have seen one positive estimate revision for the company’s annual earnings within the past 60 days. Arotech has been grabbing headlines throughout the year, which has helped it gain positive sentiment from investors. In early February, the company sold about 1.5 million shares of its stock to investment firm Admiralty Partners, generating about $3 million in revenue. Later that month, Arotech made a massive sale of 70,000 rechargeable batteries to the government of Israel, with delivery scheduled to begin in the fourth quarter of 2016. Finally, Arotech has shown promising growth signs. The company’s earnings are expected to grow by over 215% on a year-over-year basis in 2016, and its projected sales growth of 13.46% smashes its stagnant industry peers. Overall, Arotech looks like a quality low-priced stock that deserves consideration from any investor looking for a solid growth stock under $10 per share. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AROTECH CORP (ARTX): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research